ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diabetes Screening Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-5T17207
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Diabetes Screening Market Research Report 2024
BUY CHAPTERS

Global Diabetes Screening Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-5T17207
Report
November 2025
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Insphero
Abbott Laboratories
American Laboratory Products Company (ALPCO)
Beckmann Coulter Inc.
Bio-Rad Laboratories Inc
F Hoffmann La Roche Ltd
Siemens AG
PTS Diagnostics

Diabetes Screening Market

The global Diabetes Screening market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Diabetes Screening leading manufacturers including InSphero AG, Abbott Laboratories, American Laboratory Products Company (ALPCO), Beckmann Coulter Inc., Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics Inc., F. Hoffmann-la Roche Ltd, Siemens AG, PTS Diagnostics, etc., dominate supply; the top five capture approximately % of global revenue, with InSphero AG leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Diabetes Screening market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Diabetes Screening Market Report

Report Metric Details
Report Name Diabetes Screening Market
Segment by Type
  • Instrument
  • Test Suite
  • Reagents
Segment by Application
  • Hospital
  • Specialty Clinic
  • Diagnostic Center
  • Home Care
  • Academic Research Institution
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company InSphero AG, Abbott Laboratories, American Laboratory Products Company (ALPCO), Beckmann Coulter Inc., Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics Inc., F. Hoffmann-la Roche Ltd, Siemens AG, PTS Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Diabetes Screening study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Diabetes Screening Market report?

Ans: The main players in the Diabetes Screening Market are InSphero AG, Abbott Laboratories, American Laboratory Products Company (ALPCO), Beckmann Coulter Inc., Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics Inc., F. Hoffmann-la Roche Ltd, Siemens AG, PTS Diagnostics

What are the Application segmentation covered in the Diabetes Screening Market report?

Ans: The Applications covered in the Diabetes Screening Market report are Hospital, Specialty Clinic, Diagnostic Center, Home Care, Academic Research Institution

What are the Type segmentation covered in the Diabetes Screening Market report?

Ans: The Types covered in the Diabetes Screening Market report are Instrument, Test Suite, Reagents

1 Study Coverage
1.1 Introduction to Diabetes Screening: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Diabetes Screening Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Instrument
1.2.3 Test Suite
1.2.4 Reagents
1.3 Market Segmentation by Application
1.3.1 Global Diabetes Screening Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Diagnostic Center
1.3.5 Home Care
1.3.6 Academic Research Institution
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Diabetes Screening Revenue Estimates and Forecasts 2020-2031
2.2 Global Diabetes Screening Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Diabetes Screening Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Diabetes Screening Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Instrument Market Size by Players
3.3.2 Test Suite Market Size by Players
3.3.3 Reagents Market Size by Players
3.4 Global Diabetes Screening Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Diabetes Screening Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Diabetes Screening Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Diabetes Screening Market Size by Type (2020-2031)
6.4 North America Diabetes Screening Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Diabetes Screening Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Diabetes Screening Market Size by Type (2020-2031)
7.4 Europe Diabetes Screening Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Diabetes Screening Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Diabetes Screening Market Size by Type (2020-2031)
8.4 Asia-Pacific Diabetes Screening Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Diabetes Screening Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Diabetes Screening Market Size by Type (2020-2031)
9.4 Central and South America Diabetes Screening Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Diabetes Screening Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Diabetes Screening Market Size by Type (2020-2031)
10.4 Middle East and Africa Diabetes Screening Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Diabetes Screening Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 InSphero AG
11.1.1 InSphero AG Corporation Information
11.1.2 InSphero AG Business Overview
11.1.3 InSphero AG Diabetes Screening Product Features and Attributes
11.1.4 InSphero AG Diabetes Screening Revenue and Gross Margin (2020-2025)
11.1.5 InSphero AG Diabetes Screening Revenue by Product in 2024
11.1.6 InSphero AG Diabetes Screening Revenue by Application in 2024
11.1.7 InSphero AG Diabetes Screening Revenue by Geographic Area in 2024
11.1.8 InSphero AG Diabetes Screening SWOT Analysis
11.1.9 InSphero AG Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Diabetes Screening Product Features and Attributes
11.2.4 Abbott Laboratories Diabetes Screening Revenue and Gross Margin (2020-2025)
11.2.5 Abbott Laboratories Diabetes Screening Revenue by Product in 2024
11.2.6 Abbott Laboratories Diabetes Screening Revenue by Application in 2024
11.2.7 Abbott Laboratories Diabetes Screening Revenue by Geographic Area in 2024
11.2.8 Abbott Laboratories Diabetes Screening SWOT Analysis
11.2.9 Abbott Laboratories Recent Developments
11.3 American Laboratory Products Company (ALPCO)
11.3.1 American Laboratory Products Company (ALPCO) Corporation Information
11.3.2 American Laboratory Products Company (ALPCO) Business Overview
11.3.3 American Laboratory Products Company (ALPCO) Diabetes Screening Product Features and Attributes
11.3.4 American Laboratory Products Company (ALPCO) Diabetes Screening Revenue and Gross Margin (2020-2025)
11.3.5 American Laboratory Products Company (ALPCO) Diabetes Screening Revenue by Product in 2024
11.3.6 American Laboratory Products Company (ALPCO) Diabetes Screening Revenue by Application in 2024
11.3.7 American Laboratory Products Company (ALPCO) Diabetes Screening Revenue by Geographic Area in 2024
11.3.8 American Laboratory Products Company (ALPCO) Diabetes Screening SWOT Analysis
11.3.9 American Laboratory Products Company (ALPCO) Recent Developments
11.4 Beckmann Coulter Inc.
11.4.1 Beckmann Coulter Inc. Corporation Information
11.4.2 Beckmann Coulter Inc. Business Overview
11.4.3 Beckmann Coulter Inc. Diabetes Screening Product Features and Attributes
11.4.4 Beckmann Coulter Inc. Diabetes Screening Revenue and Gross Margin (2020-2025)
11.4.5 Beckmann Coulter Inc. Diabetes Screening Revenue by Product in 2024
11.4.6 Beckmann Coulter Inc. Diabetes Screening Revenue by Application in 2024
11.4.7 Beckmann Coulter Inc. Diabetes Screening Revenue by Geographic Area in 2024
11.4.8 Beckmann Coulter Inc. Diabetes Screening SWOT Analysis
11.4.9 Beckmann Coulter Inc. Recent Developments
11.5 Bio-Rad Laboratories Inc.
11.5.1 Bio-Rad Laboratories Inc. Corporation Information
11.5.2 Bio-Rad Laboratories Inc. Business Overview
11.5.3 Bio-Rad Laboratories Inc. Diabetes Screening Product Features and Attributes
11.5.4 Bio-Rad Laboratories Inc. Diabetes Screening Revenue and Gross Margin (2020-2025)
11.5.5 Bio-Rad Laboratories Inc. Diabetes Screening Revenue by Product in 2024
11.5.6 Bio-Rad Laboratories Inc. Diabetes Screening Revenue by Application in 2024
11.5.7 Bio-Rad Laboratories Inc. Diabetes Screening Revenue by Geographic Area in 2024
11.5.8 Bio-Rad Laboratories Inc. Diabetes Screening SWOT Analysis
11.5.9 Bio-Rad Laboratories Inc. Recent Developments
11.6 Ortho Clinical Diagnostics Inc.
11.6.1 Ortho Clinical Diagnostics Inc. Corporation Information
11.6.2 Ortho Clinical Diagnostics Inc. Business Overview
11.6.3 Ortho Clinical Diagnostics Inc. Diabetes Screening Product Features and Attributes
11.6.4 Ortho Clinical Diagnostics Inc. Diabetes Screening Revenue and Gross Margin (2020-2025)
11.6.5 Ortho Clinical Diagnostics Inc. Recent Developments
11.7 F. Hoffmann-la Roche Ltd
11.7.1 F. Hoffmann-la Roche Ltd Corporation Information
11.7.2 F. Hoffmann-la Roche Ltd Business Overview
11.7.3 F. Hoffmann-la Roche Ltd Diabetes Screening Product Features and Attributes
11.7.4 F. Hoffmann-la Roche Ltd Diabetes Screening Revenue and Gross Margin (2020-2025)
11.7.5 F. Hoffmann-la Roche Ltd Recent Developments
11.8 Siemens AG
11.8.1 Siemens AG Corporation Information
11.8.2 Siemens AG Business Overview
11.8.3 Siemens AG Diabetes Screening Product Features and Attributes
11.8.4 Siemens AG Diabetes Screening Revenue and Gross Margin (2020-2025)
11.8.5 Siemens AG Recent Developments
11.9 PTS Diagnostics
11.9.1 PTS Diagnostics Corporation Information
11.9.2 PTS Diagnostics Business Overview
11.9.3 PTS Diagnostics Diabetes Screening Product Features and Attributes
11.9.4 PTS Diagnostics Diabetes Screening Revenue and Gross Margin (2020-2025)
11.9.5 PTS Diagnostics Recent Developments
12 Diabetes ScreeningIndustry Chain Analysis
12.1 Diabetes Screening Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Diabetes Screening Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Diabetes Screening Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Insphero
Abbott Laboratories
American Laboratory Products Company (ALPCO)
Beckmann Coulter Inc.
Bio-Rad Laboratories Inc
F Hoffmann La Roche Ltd
Siemens AG
PTS Diagnostics
List of Tables
 Table 1. Global Diabetes Screening Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Diabetes Screening Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Diabetes Screening Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Diabetes Screening Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Diabetes Screening Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Diabetes Screening Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Diabetes Screening Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Diabetes Screening by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Screening as of 2024)
 Table 11. Global Diabetes Screening Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Diabetes Screening Companies Headquarters
 Table 13. Global Diabetes Screening Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Diabetes Screening Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Diabetes Screening Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Diabetes Screening Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Diabetes Screening Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Diabetes Screening High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Diabetes Screening Growth Accelerators and Market Barriers
 Table 25. North America Diabetes Screening Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Diabetes Screening Growth Accelerators and Market Barriers
 Table 27. Europe Diabetes Screening Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Diabetes Screening Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Diabetes Screening Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Diabetes Screening Investment Opportunities and Key Challenges
 Table 31. Central and South America Diabetes Screening Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Diabetes Screening Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Diabetes Screening Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. InSphero AG Corporation Information
 Table 35. InSphero AG Description and Major Businesses
 Table 36. InSphero AG Product Features and Attributes
 Table 37. InSphero AG Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. InSphero AG Revenue Proportion by Product in 2024
 Table 39. InSphero AG Revenue Proportion by Application in 2024
 Table 40. InSphero AG Revenue Proportion by Geographic Area in 2024
 Table 41. InSphero AG Diabetes Screening SWOT Analysis
 Table 42. InSphero AG Recent Developments
 Table 43. Abbott Laboratories Corporation Information
 Table 44. Abbott Laboratories Description and Major Businesses
 Table 45. Abbott Laboratories Product Features and Attributes
 Table 46. Abbott Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Abbott Laboratories Revenue Proportion by Product in 2024
 Table 48. Abbott Laboratories Revenue Proportion by Application in 2024
 Table 49. Abbott Laboratories Revenue Proportion by Geographic Area in 2024
 Table 50. Abbott Laboratories Diabetes Screening SWOT Analysis
 Table 51. Abbott Laboratories Recent Developments
 Table 52. American Laboratory Products Company (ALPCO) Corporation Information
 Table 53. American Laboratory Products Company (ALPCO) Description and Major Businesses
 Table 54. American Laboratory Products Company (ALPCO) Product Features and Attributes
 Table 55. American Laboratory Products Company (ALPCO) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. American Laboratory Products Company (ALPCO) Revenue Proportion by Product in 2024
 Table 57. American Laboratory Products Company (ALPCO) Revenue Proportion by Application in 2024
 Table 58. American Laboratory Products Company (ALPCO) Revenue Proportion by Geographic Area in 2024
 Table 59. American Laboratory Products Company (ALPCO) Diabetes Screening SWOT Analysis
 Table 60. American Laboratory Products Company (ALPCO) Recent Developments
 Table 61. Beckmann Coulter Inc. Corporation Information
 Table 62. Beckmann Coulter Inc. Description and Major Businesses
 Table 63. Beckmann Coulter Inc. Product Features and Attributes
 Table 64. Beckmann Coulter Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Beckmann Coulter Inc. Revenue Proportion by Product in 2024
 Table 66. Beckmann Coulter Inc. Revenue Proportion by Application in 2024
 Table 67. Beckmann Coulter Inc. Revenue Proportion by Geographic Area in 2024
 Table 68. Beckmann Coulter Inc. Diabetes Screening SWOT Analysis
 Table 69. Beckmann Coulter Inc. Recent Developments
 Table 70. Bio-Rad Laboratories Inc. Corporation Information
 Table 71. Bio-Rad Laboratories Inc. Description and Major Businesses
 Table 72. Bio-Rad Laboratories Inc. Product Features and Attributes
 Table 73. Bio-Rad Laboratories Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Bio-Rad Laboratories Inc. Revenue Proportion by Product in 2024
 Table 75. Bio-Rad Laboratories Inc. Revenue Proportion by Application in 2024
 Table 76. Bio-Rad Laboratories Inc. Revenue Proportion by Geographic Area in 2024
 Table 77. Bio-Rad Laboratories Inc. Diabetes Screening SWOT Analysis
 Table 78. Bio-Rad Laboratories Inc. Recent Developments
 Table 79. Ortho Clinical Diagnostics Inc. Corporation Information
 Table 80. Ortho Clinical Diagnostics Inc. Description and Major Businesses
 Table 81. Ortho Clinical Diagnostics Inc. Product Features and Attributes
 Table 82. Ortho Clinical Diagnostics Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Ortho Clinical Diagnostics Inc. Recent Developments
 Table 84. F. Hoffmann-la Roche Ltd Corporation Information
 Table 85. F. Hoffmann-la Roche Ltd Description and Major Businesses
 Table 86. F. Hoffmann-la Roche Ltd Product Features and Attributes
 Table 87. F. Hoffmann-la Roche Ltd Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. F. Hoffmann-la Roche Ltd Recent Developments
 Table 89. Siemens AG Corporation Information
 Table 90. Siemens AG Description and Major Businesses
 Table 91. Siemens AG Product Features and Attributes
 Table 92. Siemens AG Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Siemens AG Recent Developments
 Table 94. PTS Diagnostics Corporation Information
 Table 95. PTS Diagnostics Description and Major Businesses
 Table 96. PTS Diagnostics Product Features and Attributes
 Table 97. PTS Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. PTS Diagnostics Recent Developments
 Table 99. Raw Materials Key Suppliers
 Table 100. Distributors List
 Table 101. Market Trends and Market Evolution
 Table 102. Market Drivers and Opportunities
 Table 103. Market Challenges, Risks, and Restraints
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources


List of Figures
 Figure 1. Diabetes Screening Product Picture
 Figure 2. Global Diabetes Screening Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Instrument Product Picture
 Figure 4. Test Suite Product Picture
 Figure 5. Reagents Product Picture
 Figure 6. Global Diabetes Screening Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Specialty Clinic
 Figure 9. Diagnostic Center
 Figure 10. Home Care
 Figure 11. Academic Research Institution
 Figure 12. Diabetes Screening Report Years Considered
 Figure 13. Global Diabetes Screening Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Diabetes Screening Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Diabetes Screening Revenue Market Share by Region (2020-2031)
 Figure 17. Global Diabetes Screening Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Instrument Revenue Market Share by Player in 2024
 Figure 20. Test Suite Revenue Market Share by Player in 2024
 Figure 21. Reagents Revenue Market Share by Player in 2024
 Figure 22. Global Diabetes Screening Revenue Market Share by Type (2020-2031)
 Figure 23. Global Diabetes Screening Revenue Market Share by Application (2020-2031)
 Figure 24. North America Diabetes Screening Revenue YoY (2020-2031) & (US$ Million)
 Figure 25. North America Top 5 Players Diabetes Screening Revenue (US$ Million) in 2024
 Figure 26. North America Diabetes Screening Revenue (US$ Million) by Type (2020 - 2031)
 Figure 27. North America Diabetes Screening Revenue (US$ Million) by Application (2020-2031)
 Figure 28. US Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 29. Canada Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 30. Mexico Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 31. Europe Diabetes Screening Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. Europe Top 5 Players Diabetes Screening Revenue (US$ Million) in 2024
 Figure 33. Europe Diabetes Screening Revenue (US$ Million) by Type (2020-2031)
 Figure 34. Europe Diabetes Screening Revenue (US$ Million) by Application (2020-2031)
 Figure 35. Germany Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 36. France Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 37. U.K. Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 38. Italy Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 39. Russia Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Diabetes Screening Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Asia-Pacific Top 8 Players Diabetes Screening Revenue (US$ Million) in 2024
 Figure 42. Asia-Pacific Diabetes Screening Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Asia-Pacific Diabetes Screening Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Indonesia Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 45. Japan Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 46. South Korea Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 47. Australia Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 48. India Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 49. Indonesia Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 50. Vietnam Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 51. Malaysia Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 52. Philippines Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 53. Singapore Diabetes Screening Revenue (2020-2031) & (US$ Million)
 Figure 54. Central and South America Diabetes Screening Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Central and South America Top 5 Players Diabetes Screening Revenue (US$ Million) in 2024
 Figure 56. Central and South America Diabetes Screening Revenue (US$ Million) by Type (2020-2031)
 Figure 57. Central and South America Diabetes Screening Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Brazil Diabetes Screening Revenue (2020-2025) & (US$ Million)
 Figure 59. Argentina Diabetes Screening Revenue (2020-2025) & (US$ Million)
 Figure 60. Middle East and Africa Diabetes Screening Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Middle East and Africa Top 5 Players Diabetes Screening Revenue (US$ Million) in 2024
 Figure 62. South America Diabetes Screening Revenue (US$ Million) by Type (2020-2031)
 Figure 63. Middle East and Africa Diabetes Screening Revenue (US$ Million) by Application (2020-2031)
 Figure 64. GCC Countries Diabetes Screening Revenue (2020-2025) & (US$ Million)
 Figure 65. Israel Diabetes Screening Revenue (2020-2025) & (US$ Million)
 Figure 66. Egypt Diabetes Screening Revenue (2020-2025) & (US$ Million)
 Figure 67. South Africa Diabetes Screening Revenue (2020-2025) & (US$ Million)
 Figure 68. Diabetes Screening Industry Chain Mapping
 Figure 69. Channels of Distribution (Direct Vs Distribution)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Diabetic Retinopathy Screening Software Market Research Report 2024
Global Medical Screen Market Research Report 2024
Diabetes Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cervical Screening Market Research Report 2024
Global Regular Health Screening Services Market Research Report 2024
Global Drug Screening System Market Research Report 2025
Global Diabetes Personal Softwares Market Research Report 2024
Global Mammography Screening Market Research Report 2024
Global In Vitro Screening Market Research Report 2025
Global Diabetes Treatment Devices Market Research Report 2024
Global Diabetes Tracking Apps Market Research Report 2024
Global Home Glucose Monitor Market Research Report 2025
Global Diabetes Care Combination Products Market Research Report 2025
Global Diabetes Testing Kit Market Research Report 2024
Global Diabetes Care Intelligence Center Market Research Report 2024
Global Cancer Screening Technology Market Research Report 2024
Global Glucobay Market Research Report 2024
Digital Diabetes Device Market
Global Glucose Tracking App Market Research Report 2024
Global Screening Machine Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions